Advertisement

Idiopathic Portal Hypertension

  • Shoichi MatsutaniEmail author
Chapter
First Online:

Abstract

Idiopathic portal hypertension (IPH) is a disease presenting as non-cirrhotic portal hypertension due to a presinusoidal portal blood flow block and increased portal blood flow with an enlarged spleen, although the etiologic factors have not been identified. IPH is most common in middle-aged females and is predominant in females versus males in the overall population in Japan. The major signs and symptoms are pancytopenia with splenomegaly and gastroesophageal varices. The clinical manifestations are relatively mild and insidious in most of the patients, except in the case of variceal hemorrhage. A high incidence of portal vein thrombosis is also characteristic. Diagnosis is made by the differentiating IPH from the diseases of portal hypertension with identified causes because there are no specific clinical findings for the diagnosis of IPH. Portal and hepatic venography or liver histology is helpful for the diagnosis. The treatment of portal hypertension-related problems is the same as for problems related to liver cirrhosis. The clinical course and overall survival are well maintained in patients for whom gastroesophageal varices are effectively controlled. However, complications such as refractory ascites or intestinal ectopic varices may appear in the late stages of the disease.

Keywords

Non-cirrhotic portal hypertension Banti disease Presinusoidal portal blood flow block Portal vein thrombosis 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Okuda K. Noncirrhotic portal hypertension. In: Okuda K, Mitchell DG, Itai Y, Ariyama J, editors. Hepatobiliary diseases pathophysiology and imaging. London: Blackwell Science; 2001. p. 287–314.Google Scholar
  2. 2.
    Banti G. Del l’anemia splenica. Arch di Scuola d’Anat Patol (Firenze). 1983;2:53–122.Google Scholar
  3. 3.
    Banti G. Ueber Morbus Banti Folia Haematol. 1910;10:33–74.Google Scholar
  4. 4.
    Hsia DYY, Gellis SS. Portal hypertension in infants and children. Am J Dig Child. 1955;90:290–8.Google Scholar
  5. 5.
    Polish E, Christie J, Cohen A, et al. Idiopathic portal hypertension (Banti’s syndrome). Ann Intern Med. 1962;56:624–7.CrossRefGoogle Scholar
  6. 6.
    Williams P, Parsonson A, Somers K. Portal hypertension in idiopathic tropical splenomegaly. Lancet I. 1966;287:329–33.CrossRefGoogle Scholar
  7. 7.
    Ramalingaswarmi B, Wig HL, Sarma SK. Cirrhosis of the liver in northern India: pathological study. Arch Intern Med. 1962;110:350–8.CrossRefGoogle Scholar
  8. 8.
    Mikkelsen WP, Edmondson HA, Peters RL, et al. Extra- and intra-hepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg. 1965;162:602–20.CrossRefGoogle Scholar
  9. 9.
    Boyer JL, Sengupta KP, Biswas SK, et al. Idiopathic portal hypertension: comparison with portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med. 1967;66:41–68.CrossRefGoogle Scholar
  10. 10.
    Schouten JNL, Garcia-Pagan JC, Valla DC, Janssen HLA. Idiopathic noncirrhotic portal hypertension. Hepatology. 2011;54:1071–81.CrossRefGoogle Scholar
  11. 11.
    Kotani K, Kawabe J, Morikawa H, et al. Comprehensive screening of gene function and networks by DNA microarray analysis in Japanese patients with idiopathic portal hypertension. Mediat Inflamm. 2015;2015:349215.  https://doi.org/10.1155/2015/349215. Epub 2015 Oct 4.CrossRefGoogle Scholar
  12. 12.
    Tsuneyama K, Harada K, Katayanagi K, et al. Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a reviewer of literature. J Gastroenterol Hepatol. 2002;17:217–23.CrossRefGoogle Scholar
  13. 13.
    Okabayashi A. Experimental production of noncirrhotic portal hypertension and splenomegaly with prolonged antigenic stimulation. In: Okuda K, Omata M, editors. Idiopathic portal hypertension. Tokyo: University of Tokyo press; 1983. p. 197–217.Google Scholar
  14. 14.
    Kono K, Ohnishi K, Omata M, et al. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic E. coli in rabbits. Gastroenterology. 1988;94:787–96.CrossRefGoogle Scholar
  15. 15.
    Akahoshi T, Hashizume M, Tanoue K, et al. Role of the spleen in liver fibrosis in rat may be mediated by growth factor beta-1. J Gastroenterol Hepatol. 2002;17:59–65.CrossRefGoogle Scholar
  16. 16.
    Sato Y, Nakanuma Y. Role of endothelial-mesenchymal transition in idiopathic portal hypertension. Histol Histopathol. 2013;28:145–54.PubMedGoogle Scholar
  17. 17.
    Morikawa H, Tamori A, Nishiguchi S, et al. Expression of connective tissue growth factor in the human liver with idiopathic portal hypertension. Mol Med. 2007;13:240–5.CrossRefGoogle Scholar
  18. 18.
    Hirota Y, Annual Report of Research Committee on Portal Hemodynamics Abnormalities, The Ministry of Health Labor and Welfare of Japan;2006:82–92 (Japanese).Google Scholar
  19. 19.
    Okudaira M, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin Liver Dis. 2002;22:59–71.CrossRefGoogle Scholar
  20. 20.
    Futagawa S, Fukazawa M, Horisawa M, et al. Portographic liver changes in idiopathic noncirrhotic portal hypertension. AJR. 1980;134:917–23.CrossRefGoogle Scholar
  21. 21.
    Okuda K, Kono K, Ohnishi K, et al. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology. 1984;86:600–10.PubMedGoogle Scholar
  22. 22.
    Futagawa S, Fukazawa M, Musha H, et al. Hepatic venography in noncirrhotic idiopathic portal hypertension. Radiology. 1981;141:303–8.CrossRefGoogle Scholar
  23. 23.
    Hillaire S, Bonte E, Denninger MH, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut. 2002;51:275–80.CrossRefGoogle Scholar
  24. 24.
    Matsutani S, Maruyama H, Akiike T, et al. Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan. Liver Int. 2005;25:978–83.CrossRefGoogle Scholar
  25. 25.
    Matsutani S. Blood coagulation inhibitors and portal vein thrombosis in patients with portal hypertension. Annual Report of Research Committee on Portal Hemodynamics Abnormalities, The Ministry of Health Labor and Welfare of Japan;2009:31–5 (Japanese).Google Scholar
  26. 26.
    Ohnishi K, Saito M, Sato S, et al. Portal hemodynamics in idiopathic portal hypertension (Banti’s syndrome) comparison with chronic persistent hepatitis and normal subjects. Gastroenterology. 1987;92:751–8.CrossRefGoogle Scholar
  27. 27.
    Furuichi Y, Moriyasu F, Taira J, et al. Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography. J Gastroenterol. 2013;48:1061–8.CrossRefGoogle Scholar
  28. 28.
    Qureshi K, Patel S, Meillier A. The use of thrombopoietin receptor agonist for correction of thrombocytopenia prior to elective procedures in chronic liver diseases: review of current evidence. Int J Hepatol. 2016;2016:1802932. Epub 2016 Oct 9.CrossRefGoogle Scholar
  29. 29.
    Ichimura S, Sasaki R, Takemura Y, et al. The prognosis of idiopathic portal hypertension in Japan. Intern Med. 1993;32:441–4.CrossRefGoogle Scholar
  30. 30.
    Murai Y, Ohfuji S, Fukushima W, et al. Prognostic factors in patients with idiopathic portal hypertension: two Japanese nationwide epidemiological surveys in 1999 and 2005. Hepatol Res. 2012;42:1211–20.CrossRefGoogle Scholar
  31. 31.
    Sawada S, Sato Y, Aoyama H, et al. Pathological study of idiopathic portal hypertension with an emphasis on cause of death based on records of annuals of pathological autopsy cases in Japan. J Gastroenterol Hepatol. 2006;22:204–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of GastroenterologyFunabashi Municipal Medical CenterFunabashiJapan

Personalised recommendations

Cite chapter

Buy options